The scientists at BSRC “Alexander Fleming” perform cutting-edge research, aiming to understand molecular mechanisms of complex biological processes in health and disease. We are also committed to contribute to innovation in medicine, by developing novel therapeutic and diagnostic methods, focusing on immunity and inflammation, cancer, and neurodegenerative diseases. To keep our focus on top-notch research, we recruit at all levels with excellence as the sole criterion and we support our researchers by providing state-of-the science infrastructures and a pleasant working environment. FLEMING is a non-profit organization operating under the auspices of the Greek General Secretariat for Research & Technology and is supported by the Greek government and by national, European and international grants.


29 July 2020

Verykokakis and colleagues revealed that the transcription factor BCL-6 controls early development of innate-like T cells, including Natural Killer T (NKT) and Mucosal-Associated Invariant T (MAIT) cells, in a new study, published in Nature Immunology.

23 July 2020

Two Open Calls for proposals for (A) mouse model development and (B) mouse phenotyping services offered FREE OF CHARGE by the InfrafrontierGR/Phenotypos research infrastructure at BSRC Fleming.

10 July 2020

BSRC Alexander Fleming joins in the National Plan for Open Science.

24 June 2020

OPEN CALL for applications for the Institute for Bioinnovation Director position of the BSRC Alexander Fleming.
Deadline: 31 August 2020.



1st LAS Core Modules Course (Webinar) - July 09-10, 2020.


BSRC Fleming supports Greek Public Health authorities in their effort to tackle the COVID-19 pandemic. Read the announcement (GR), (ENG).


Visit BSRC Fleming's scientific Publications web page


Visit BSRC Fleming's funding web page


For internal users


For internal users

B.S.R.C. "Alexander Fleming"
34 Fleming Street, 16672 Vari, Greece
Contact us - Privacy Policy